1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > United States Advanced Wound Management Market Outlook to 2020

United States Advanced Wound Management Market Outlook to 2020

Summary

GlobalData’s new report, "United States Advanced Wound Management Market Outlook to 2020", provides key market data on the United States Advanced Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Semi-Permeable Films (Antimicrobial Film Dressings (Antimicrobial Bordered and Non Bordered Film Dressings) and Non Antimicrobial Film Dressings (Non Antimicrobial Bordered and Non Bordered Film Dressings)), Foams (Antimicrobial Foam Dressings (Antimicrobial Bordered and Non Bordered Foam Dressings) and Non Antimicrobial Foam Dressings (Non Antimicrobial Bordered and Non Bordered Foam Dressings)), Hydrofibres (Antimicrobial and Non Antimicrobial Hydrofibre Dressings), Hydrocolloids (Antimicrobial and Non Antimicrobial Hydrocolloid Dressings), Hydrogels (Antimicrobial and Non Antimicrobial Hydrogel Dressings), Alginates (Antimicrobial and Non Antimicrobial Alginate Dressings), Collagens (Antimicrobial and Non Antimicrobial Collagen Dressings), Wound Contact Layers (Antimicrobial and Non Antimicrobial Wound Contact Layers) and Superabsorbents (Antimicrobial and Non Antimicrobial Superabsorbents).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Advanced Wound Management market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size data for Advanced Wound Management market segments - Semi-Permeable Films, Foams, Hydrofibres, Hydrocolloids, Hydrogels, Alginates, Collagens, Wound Contact Layers and Superabsorbents.
- Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
- 2013 company shares and distribution shares data for Advanced Wound Management market.
- Global corporate-level profiles of key companies operating within the United States Advanced Wound Management market.
- Key players covered include 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Advanced Wound Management Market Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Advanced Wound Management Market Segmentation 12
2.3 Definitions of Markets Covered in the Report 14
3 Advanced Wound Management Market, United States 17
3.1 Advanced Wound Management Market, United States, Revenue ($m), 2005-2013 17
3.2 Advanced Wound Management Market, United States, Revenue ($m), 2013-2020 19
3.2.1 Alginates Market, United States, Revenue ($m), by Segment, 2005-2013 21
3.2.2 Collagens Market, United States, Revenue ($m), by Segment, 2005-2013 22
3.2.3 Foams Market, United States, Revenue ($m), by Segment, 2005-2013 23
3.2.3.1 Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013 25
3.2.3.2 Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013 27
3.2.4 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2005-2013 29
3.2.5 Hydrofibres Market, United States, Revenue ($m), by Segment, 2005-2013 31
3.2.6 Hydrogels Market, United States, Revenue ($m), by Segment, 2005-2013 33
3.2.7 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2005-2013 35
3.2.7.1 Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013 37
3.2.7.2 Non Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2005-2013 39
3.2.8 Superabsorbents Market, United States, Revenue ($m), by Segment, 2005-2013 41
3.2.9 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2005-2013 43
3.2.10 Alginates Market, United States, Revenue ($m), by Segment, 2013-2020 45
3.2.11 Collagens Market, United States, Revenue ($m), by Segment, 2013-2020 47
3.2.12 Foams Market, United States, Revenue ($m), by Segment, 2013-2020 49
3.2.12.1 Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020 51
3.2.12.2 Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020 53
3.2.13 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2013-2020 55
3.2.14 Hydrofibres Market, United States, Revenue ($m), by Segment, 2013-2020 57
3.2.15 Hydrogels Market, United States, Revenue ($m), by Segment, 2013-2020 59
3.2.16 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2013-2020 60
3.2.16.1 Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020 62
3.2.16.2 Non Antimicrobial Film Dressings Market, United States, Revenue ($m), by Sub Segment, 2013-2020 64
3.2.17 Superabsorbents Market, United States, Revenue ($m), by Segment, 2013-2020 66
3.2.18 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2013-2020 68
3.3 Advanced Wound Management Market, United States, Volume (Units), 2005-2013 70
3.4 Advanced Wound Management Market, United States, Volume (Units), 2013-2020 72
3.4.1 Alginates Market, United States, Volume (Units), by Segment, 2005-2013 74
3.4.2 Collagens Market, United States, Volume (Units), by Segment, 2005-2013 76
3.4.3 Foams Market, United States, Volume (Units), by Segment, 2005-2013 78
3.4.3.1 Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013 80
3.4.3.2 Non Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013 82
3.4.4 Hydrocolloids Market, United States, Volume (Units), by Segment, 2005-2013 84
3.4.5 Hydrofibres Market, United States, Volume (Units), by Segment, 2005-2013 86
3.4.6 Hydrogels Market, United States, Volume (Units), by Segment, 2005-2013 88
3.4.7 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2005-2013 90
3.4.7.1 Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013 92
3.4.7.2 Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2005-2013 94
3.4.8 Superabsorbents Market, United States, Volume (Units), by Segment, 2005-2013 96
3.4.9 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2005-2013 98
3.4.10 Alginates Market, United States, Volume (Units), by Segment, 2013-2020 100
3.4.11 Collagens Market, United States, Volume (Units), by Segment, 2013-2020 102
3.4.12 Foams Market, United States, Volume (Units), by Segment, 2013-2020 104
3.4.12.1 Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020 106
3.4.12.2 Non Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020 108
3.4.13 Hydrocolloids Market, United States, Volume (Units), by Segment, 2013-2020 110
3.4.14 Hydrofibres Market, United States, Volume (Units), by Segment, 2013-2020 112
3.4.15 Hydrogels Market, United States, Volume (Units), by Segment, 2013-2020 114
3.4.16 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2013-2020 116
3.4.16.1 Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020 118
3.4.16.2 Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, 2013-2020 120
3.4.17 Superabsorbents Market, United States, Volume (Units), by Segment, 2013-2020 122
3.4.18 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2013-2020 124
3.5 Advanced Wound Management Market, United States, Average Price ($), 2005-2020 126
3.6 Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2012-2013 130
3.7 Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2012-2013 131
4 Overview of Key Companies in United States, Advanced Wound Management Market 133
4.1 3M Health Care Ltd 133
4.1.1 Company Overview 133
4.2 Smith and Nephew Plc 133
4.2.1 Company Overview 133
4.3 Medline Industries, Inc. 133
4.3.1 Company Overview 133
4.4 Molnlycke Health Care AB 133
4.4.1 Company Overview 133
4.5 Coloplast A/S 134
4.5.1 Company Overview 134
4.6 Systagenix Wound Management Limited 134
4.6.1 Company Overview 134
4.7 Covidien plc 134
4.7.1 Company Overview 134
4.8 BSN medical GmbH 135
4.8.1 Company Overview 135
4.9 Derma Sciences, Inc. 135
4.9.1 Company Overview 135
4.10 Paul Hartmann AG 135
4.10.1 Company Overview 135
4.11 Hollister Incorporated 136
4.11.1 Company Overview 136
4.12 Laboratoires Urgo S.A. 136
4.12.1 Company Overview 136
4.13 ConvaTec Inc. 136
4.13.1 Company Overview 136
5 Advanced Wound Management Market Pipeline Products 137
6 Financial Deals Landscape 140
6.1 Acquisition 140
6.1.1 Avista Capital Partners and Nordic Capital May Sell ConvaTec 140
6.1.2 Medtronic May Acquire Smith and Nephew 142
6.1.3 Smith and Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million 143
6.2 Equity Offerings 145
6.2.1 Dara BioSciences Raises USD12.5 Million in Public Offering of Units 145
6.2.2 Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 146
6.2.3 Sanuwave Health Completes Private Placement Of Shares For US$10 Million 147
6.2.4 Dara BioSciences Announces Private Placement Of Shares For US$6 Million 148
6.2.5 Sanuwave Health Completes Private Placement Of Shares For US$0.3 Million 150
6.2.6 Sanuwave Health Completes Private Placement Of Shares For US$0.2 Million 151
6.2.7 Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 152
6.2.8 Sanuwave Health Completes Private Placement Of Shares For US$0.1 Million 154
6.3 Partnerships 155
6.3.1 Medline Industries Enters Into Licensing Agreement With Quick-Med For Stay-Fresh Antimicrobial Technology 155
6.3.2 Sanuwave Health And Wirthlin Form Joint Venture 156
6.3.3 Sarasota Medical Enters Into Licensing Agreement With Quick-Med Technologies For Stay-Fresh Antimicrobial Technology 157
6.3.4 PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb 158
6.4 Private Equity 159
6.4.1 Private Equity Owners Evaluate Options For Biomet Exit 159
6.5 Venture Financing 161
6.5.1 PolyRemedy Raises USD5 Million in Venture Financing 161
6.5.2 St. Teresa Medical Raises USD1.13 Million in Venture Financing 162
6.5.3 Chitogen Raises US$0.1 Million In Venture Financing 163
6.5.4 St. Teresa Medical Raises USD0.7 Million in Venture Financing 164
6.5.5 Vomaris Innovations Raises US$5 Million In Venture Financing 165
6.5.6 Soluble Systems Raises US$3.5 Million In Venture Financing 166
7 Recent Developments 167
7.1 Corporate Communications 167
7.1.1 Sep 29, 2014: AHS Leader Wright Lassiter New President of Henry Ford Health System 167
7.1.2 Jul 22, 2014: ConvaTec Names Nigel Clerkin Chief Financial Officer 167
7.1.3 Jul 09, 2014: Spiracur Appoints Chris Fashek as Its New President and CEO 168
7.1.4 Jun 17, 2014: DARA BioSciences Announces Leadership Transition 168
7.1.5 Apr 21, 2014: SANUWAVE Health Announces Executive Changes 169
7.1.6 Mar 25, 2014: Chesapeake IRB Acquires Goodwyn IRB 170
7.1.7 Mar 06, 2014: Henry Ford West Bloomfield Hospital Names Chief Medical Officer 171
7.1.8 Feb 25, 2014: DARA BioSciences Regains Compliance With NASDAQ Bid Price Requirement 171
7.1.9 Jan 27, 2014: John Cannon Named CFO of ConvaTec 172
7.1.10 Dec 09, 2013: ACell Nearly Doubles Board of Directors with Addition of Three Members 172
7.1.11 Nov 12, 2013: NASDAQ Grants DARA BioSciences 180-Day Extension to Regain Compliance With Bid Price Requirement 173
7.1.12 Nov 05, 2013: ImmunoGen Initiates Phase I Testing of Its EGFR-Targeting ADC, IMGN289 173
7.1.13 Oct 28, 2013: DARA BioSciences Announces Sales Force Expansion and Agreement With Mission Pharmacal in the Oncology Market 174
7.1.14 Oct 28, 2013: President and CEO Announced for HF West Bloomfield Hospital 175
7.2 Financial Announcements 176
7.2.1 Aug 15, 2014: ULURU Reports Second Quarter 2014 Financial Results 176
7.2.2 Aug 12, 2014: DARA BioSciences Announces Second Quarter 2014 Results 178
7.2.3 Aug 07, 2014: Derma Sciences Reports Second Quarter Financial Results 179
7.2.4 Aug 06, 2014: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update 182
7.2.5 Jun 17, 2014: OrthAlign Announces US FDA Clearance for ORTHALIGN PLUS, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery: Cup Placement, Leg Length, and Offset 183
7.2.6 May 16, 2014: ULURU Inc. Reports First Quarter 2014 Financial Results 186
7.2.7 May 13, 2014: SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update 188
7.2.8 May 12, 2014: DARA BioSciences Announces First Quarter 2014 Results 189
7.2.9 May 08, 2014: Derma Sciences Reports First Quarter Financial Results 190
7.2.10 May 06, 2014: ConvaTec Reports Strong Financial Results for Fiscal Year 2013 192
7.2.11 Apr 10, 2014: Abbott Completes Enrollment of Absorb Randomized Clinical Trials in the United States, Japan and China 192
7.2.12 Apr 01, 2014: ULURU Reports Financial Results For Fourth Quarter And Year Ending December 31, 2013 195
7.2.13 Mar 14, 2014: Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products 197
7.2.14 Feb 04, 2014: DARA Reports 2013 Fourth Quarter and Full Year Financial Results and Commercial Business Update 199
7.2.15 Jan 22, 2014: BIOTRONIK Enrolls First Patients in Expansion of ProMRI Clinical Trial 201
7.2.16 Jan 16, 2014: Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance 203
7.2.17 Nov 15, 2013: ULURU Reports Third Quarter 2013 Financial Results 203
7.2.18 Nov 14, 2013: DARA Reports Third Quarter 2013 Financial Results and Highlights Commercial Momentum on Synergistic Oncology Supportive Care Product Portfolio 205
7.2.19 Nov 14, 2013: ConvaTec announces 2013 third quarter earnings call 207
7.2.20 Nov 13, 2013: Derma Sciences Reports Third Quarter Financial Results 207
7.2.21 Nov 12, 2013: ULURU Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013 208
7.2.22 Nov 12, 2013: DARA BioSciences to Announce Third Quarter 2013 Financial Results and Corporate Business Update on November 14, 2013 209
7.2.23 Nov 07, 2013: SANUWAVE to Hold Third Quarter Financial Results Conference Call on Tuesday, November 12 209
7.2.24 Nov 06, 2013: Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 13th 209
7.2.25 Oct 31, 2013: Isolite Systems Launches Isovac Dental Isolation Adapter 209
7.3 Government and Public Interest 210
7.3.1 Dec 09, 2013: Henry Ford Hospital Performs Minimally Invasive Laser Brain Surgeries 210
7.3.2 Dec 04, 2013: Derma Sciences to Present at the Oppenheimer and Co. Inc. 24th Annual Healthcare Conference 211
7.3.3 Nov 25, 2013: Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference 211
7.3.4 Nov 12, 2013: Derma Sciences to Participate in the Canaccord Genuity Medical Technology and Diagnostics Forum 212
7.4 Legal And Regulatory 212
7.4.1 Jan 09, 2014: CareFusion Issues Statement About Previously Disclosed Government Settlement 212
7.5 Other Significant Developments 212
7.5.1 Jul 24, 2014: Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing 212
7.5.2 Jul 22, 2014: Henry Ford Health System named finalist for AHA's inaugural Equity of Care Award 213
7.5.3 Mar 25, 2014: Henry Ford Joins Largest Health Information Exchange in Michigan 214
7.5.4 Mar 24, 2014: HemCon Medical Technologies Revenue Growth Surges in Japan 215
7.5.5 Mar 12, 2014: Henry Ford Hospital Heart Study Wins Award 215
7.5.6 Feb 26, 2014: ULURU Provides Business Update 216
7.5.7 Feb 04, 2014: JFCI Awarded 3-Year Accreditation from American College of Surgeons 216
7.5.8 Jan 21, 2014: Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 217
7.5.9 Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases 218
7.5.10 Oct 28, 2013: MRIGlobal Wins Subcontract to Evaluate New Treatment for Wound Care 219
7.6 Product News 219
7.6.1 Jun 03, 2014: DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Effect Management 219
7.6.2 Feb 25, 2014: Study Finds That Consumers Prefer Regenica Overnight Repair To SkinMedica TNS Essential Serum 220
7.6.3 Feb 17, 2014: Clinical Trial to Study Genetics of Keloid Scars 221
7.6.4 Jan 16, 2014: ConvaTec Announces New Continuing Education Courses in Wound and Skin Care 221
7.6.5 Jan 14, 2014: ConvaTec Launches Ostomysecrets in Europe 222
7.6.6 Dec 16, 2013: Henry Ford Implants New Defibrillator for Sudden Cardiac Arrest 222
7.6.7 Nov 18, 2013: BioLargo Granted Additional Patent as It Lands Second Order From US Government 223
7.6.8 Nov 13, 2013: CareFusion Updates Labeling For ChloraPrep Products 224
7.7 Strategy And Business Planning 224
7.7.1 Jun 23, 2014: Neuro Resource Group's Hospital Presence Continues to Expand 224
7.7.2 Feb 26, 2014: Henry Ford Hospital Opens Pigmented Lesions Clinic 225
7.7.3 Feb 11, 2014: ConvaTec To Close Skillman Office In New Jersey 225
7.7.4 Jan 24, 2014: Henry Ford Innovations Joins Carnegie Mellon Center 225
7.7.5 Jan 22, 2014: Henry Ford Innovations Establishes William Davidson Center 226
7.7.6 Oct 25, 2013: ACell Expands Indiana Manufacturing Facility to Support Growth 227
8 Appendix 228
8.1 Research Methodology 229
8.1.1 Coverage 229
8.1.2 Secondary Research 229
8.1.3 Primary Research 230
8.1.4 Market Modeling and Forecasting 231
8.1.5 Company Share Analysis 234
8.1.6 Distribution Share Analysis 235
8.2 Expert Panel 235
8.3 GlobalData Consulting 236
8.4 Contact Us 236
8.5 Disclaimer 236

1.1 List of Tables
Table 1: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 18
Table 2: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 20
Table 3: Alginates Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 21
Table 4: Collagens Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 22
Table 5: Foams Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 24
Table 6: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 26
Table 7: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 28
Table 8: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 30
Table 9: Hydrofibres Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 32
Table 10: Hydrogels Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 34
Table 11: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 36
Table 12: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 38
Table 13: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 40
Table 14: Superabsorbents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 42
Table 15: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 44
Table 16: Alginates Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 46
Table 17: Collagens Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 48
Table 18: Foams Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 50
Table 19: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 52
Table 20: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 54
Table 21: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 56
Table 22: Hydrofibres Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 58
Table 23: Hydrogels Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 59
Table 24: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 61
Table 25: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 63
Table 26: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 65
Table 27: Superabsorbents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 67
Table 28: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 69
Table 29: Advanced Wound Management Market, United States, Volume (Units), Historic, 2005-2013 71
Table 30: Advanced Wound Management Market, United States, Volume (Units), Forecast, 2013-2020 73
Table 31: Alginates Market, United States, Volume (Units), Historic, 2005-2013 75
Table 32: Collagens Market, United States, Volume (Units), Historic, 2005-2013 77
Table 33: Foams Market, United States, Volume (Units), Historic, 2005-2013 79
Table 34: Antimicrobial Foam Dressings Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 81
Table 35: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013 83
Table 36: Hydrocolloids Market, United States, Volume (Units), Historic, 2005-2013 85
Table 37: Hydrofibres Market, United States, Volume (Units), Historic, 2005-2013 87
Table 38: Hydrogels Market, United States, Volume (Units), Historic, 2005-2013 89
Table 39: Semi-Permeable Films Market, United States, Volume (Units), Historic, 2005-2013 91
Table 40: Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013 93
Table 41: Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 95
Table 42: Superabsorbents Market, United States, Volume (Units), Historic, 2005-2013 97
Table 43: Wound Contact Layers Market, United States, Volume (Units), Historic, 2005-2013 99
Table 44: Alginates Market, United States, Volume (Units), Forecast, 2013-2020 101
Table 45: Collagens Market, United States, Volume (Units), Forecast, 2013-2020 103
Table 46: Foams Market, United States, Volume (Units), Forecast, 2013-2020 105
Table 47: Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020 107
Table 48: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020 109
Table 49: Hydrocolloids Market, United States, Volume (Units), Forecast, 2013-2020 111
Table 50: Hydrofibres Market, United States, Volume (Units), Forecast, 2013-2020 113
Table 51: Hydrogels Market, United States, Volume (Units), Forecast, 2013-2020 115
Table 52: Semi-Permeable Films Market, United States, Volume (Units), Forecast, 2013-2020 117
Table 53: Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020 119
Table 54: Non Antimicrobial Film Dressings Market, United States, Volume (Units), by Sub Segment, Forecast, 2013-2020 121
Table 55: Superabsorbents Market, United States, Volume (Units), Forecast, 2013-2020 123
Table 56: Wound Contact Layers Market, United States, Volume (Units), Forecast, 2013-2020 125
Table 57: Advanced Wound Management Market, United States, Average Price ($), Historic, 2005-2013 126
Table 58: Advanced Wound Management Market, United States, Average Price ($), Forecast, 2013-2020 128
Table 59: Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013 130
Table 60: Advanced Wound Management Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013 132
Table 61: Advanced Wound Management Market Pipeline Products 137
Table 62: Avista Capital Partners and Nordic Capital May Sell ConvaTec 140
Table 63: Medtronic May Acquire Smith and Nephew 142
Table 64: Smith and Nephew Completes Acquisition Of Healthpoint Biotherapeutics, Wound Care Company, For US$782 Million 143
Table 65: Dara BioSciences Raises USD12.5 Million in Public Offering of Units 145
Table 66: Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 146
Table 67: Sanuwave Health Completes Private Placement Of Shares For US$10 Million 147
Table 68: Dara BioSciences Announces Private Placement Of Shares For US$6 Million 148
Table 69: Sanuwave Health Completes Private Placement Of Shares For US$0.3 Million 150
Table 70: Sanuwave Health Completes Private Placement Of Shares For US$0.2 Million 151
Table 71: Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 152
Table 72: Sanuwave Health Completes Private Placement Of Shares For US$0.1 Million 154
Table 73: Medline Industries Enters Into Licensing Agreement With Quick-Med For Stay-Fresh Antimicrobial Technology 155
Table 74: Sanuwave Health And Wirthlin Form Joint Venture 156
Table 75: Sarasota Medical Enters Into Licensing Agreement With Quick-Med Technologies For Stay-Fresh Antimicrobial Technology 157
Table 76: PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb 158
Table 77: Private Equity Owners Evaluate Options For Biomet Exit 159
Table 78: PolyRemedy Raises USD5 Million in Venture Financing 161
Table 79: St. Teresa Medical Raises USD1.13 Million in Venture Financing 162
Table 80: Chitogen Raises US$0.1 Million In Venture Financing 163
Table 81: St. Teresa Medical Raises USD0.7 Million in Venture Financing 164
Table 82: Vomaris Innovations Raises US$5 Million In Venture Financing 165
Table 83: Soluble Systems Raises US$3.5 Million In Venture Financing 166
Table 84: Total Number of Primary Research Participants, Wound Care Management, by Country 231

1.2 List of Figures
Figure 1: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 17
Figure 2: Advanced Wound Management Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 19
Figure 3: Alginates Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 21
Figure 4: Collagens Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 22
Figure 5: Foams Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 23
Figure 6: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 25
Figure 7: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 27
Figure 8: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 29
Figure 9: Hydrofibres Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 31
Figure 10: Hydrogels Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 33
Figure 11: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 35
Figure 12: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 37
Figure 13: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 39
Figure 14: Superabsorbents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 41
Figure 15: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 43
Figure 16: Alginates Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 45
Figure 17: Collagens Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 47
Figure 18: Foams Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 49
Figure 19: Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 51
Figure 20: Non Antimicrobial Foam Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 53
Figure 21: Hydrocolloids Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 55
Figure 22: Hydrofibres Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 57
Figure 23: Hydrogels Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 59
Figure 24: Semi-Permeable Films Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 60
Figure 25: Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 62
Figure 26: Non Antimicrobial Film Dressings Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 64
Figure 27: Superabsorbents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 66
Figure 28: Wound Contact Layers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 68
Figure 29: Advanced Wound Management Market, United States, Volume (Units), Historic, 2005-2013 70
Figure 30: Advanced Wound Management Market, United States, Volume (Units), Forecast, 2013-2020 72
Figure 31: Alginates Market, United States, Volume (Units), Historic, 2005-2013 74
Figure 32: Collagens Market, United States, Volume (Units), Historic, 2005-2013 76
Figure 33: Foams Market, United States, Volume (Units), Historic, 2005-2013 78
Figure 34: Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013 80
Figure 35: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Historic, 2005-2013 82
Figure 36: Hydrocolloids Market, United States, Volume (Units), Historic, 2005-2013 84
Figure 37: Hydrofibres Market, United States, Volume (Units), Historic, 2005-2013 86
Figure 38: Hydrogels Market, United States, Volume (Units), Historic, 2005-2013 88
Figure 39: Semi-Permeable Films Market, United States, Volume (Units), Historic, 2005-2013 90
Figure 40: Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013 92
Figure 41: Non Antimicrobial Film Dressings Market, United States, Volume (Units), Historic, 2005-2013 94
Figure 42: Superabsorbents Market, United States, Volume (Units), Historic, 2005-2013 96
Figure 43: Wound Contact Layers Market, United States, Volume (Units), Historic, 2005-2013 98
Figure 44: Alginates Market, United States, Volume (Units), Forecast, 2013-2020 100
Figure 45: Collagens Market, United States, Volume (Units), Forecast, 2013-2020 102
Figure 46: Foams Market, United States, Volume (Units), Forecast, 2013-2020 104
Figure 47: Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020 106
Figure 48: Non Antimicrobial Foam Dressings Market, United States, Volume (Units), Forecast, 2013-2020 108
Figure 49: Hydrocolloids Market, United States, Volume (Units), Forecast, 2013-2020 110
Figure 50: Hydrofibres Market, United States, Volume (Units), Forecast, 2013-2020 112
Figure 51: Hydrogels Market, United States, Volume (Units), Forecast, 2013-2020 114
Figure 52: Semi-Permeable Films Market, United States, Volume (Units), Forecast, 2013-2020 116
Figure 53: Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020 118
Figure 54: Non Antimicrobial Film Dressings Market, United States, Volume (Units), Forecast, 2013-2020 120
Figure 55: Superabsorbents Market, United States, Volume (Units), Forecast, 2013-2020 122
Figure 56: Wound Contact Layers Market, United States, Volume (Units), Forecast, 2013-2020 124
Figure 57: Advanced Wound Management Market, United States, Company Share (%), 2013 131
Figure 58: GlobalData Epidemiology-Based Forecasting Model 233
Figure 59: GlobalData Capital Equipment-Based Forecasting Model 234
Figure 60: Primary Interviews by Participant Type (%) 235

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Antimicrobial Medical Textiles Market Analysis By Finishing Agent, By Application And Segment Forecasts To 2024

Antimicrobial Medical Textiles Market Analysis By Finishing Agent, By Application And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The global antimicrobial medical textiles market is expected to reach USD 799.7 million by 2024, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases, an upsurge ...

Antimicrobial Packaging Market by Base Material, Antimicrobial Agents, Technology, Pack Type, Application - Forecast to 2021

Antimicrobial Packaging Market by Base Material, Antimicrobial Agents, Technology, Pack Type, Application - Forecast to 2021

  • $ 9000
  • Industry report
  • May 2016
  • by MarketsandMarkets

“Increasing demand from the food & beverages industry to drive the antimicrobial packaging market” The antimicrobial packaging market size is estimated to grow from USD 7.28 billion in 2015 to USD ...

Antimicrobial Coatings For Medical Devices Market - By Type Of Material [Metallic Coatings (Silver, Copper), Non-Metallic Coatings (Polymeric , Organic & Others)], By Device Type (Catheters, Implantable Devices, Surgical Instruments, Others) -Forecast 201

Antimicrobial Coatings For Medical Devices Market - By Type Of Material [Metallic Coatings (Silver, Copper), Non-Metallic Coatings (Polymeric , Organic & Others)], By Device Type (Catheters, Implantable Devices, Surgical Instruments, Others) -Forecast 201

  • $ 5250
  • Industry report
  • March 2016
  • by Industry ARC

Antimicrobial coated film is ideal overlay material that can be used to destroy the growth of microorganisms. Antimicrobial coating is a direct response to the growing emphasis on hygiene, and bacteria ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.